Dr. Ilian Iliev, Chief Executive Officer, is Managing Director of EMV Capital, a London-based investor in B2B companies in the industrial high-tech, energy, circular economy, smart cities and transportation sectors and healthcare. EMVC’s investments in Europe, Israel and the US cover a range of technologies including robotics and AI, machine learning, materials science, IoT, advanced engineering, power electronics and medical devices. Ilian spun-out EMV Capital out of EcoMachines Ventures, which he co-founded in 2013. Prior to that he co-founded and was CEO of CambridgeIP Ltd (2006-2012), which he built into a leading market and technology business intelligence provider in the UK. He is a Board member at a number of EMVC portfolio companies, including Sofant Technologies, Pointgrab, Q-Bot, Vortex Biosciences and Wanda Health.
Ilian holds a PhD from Cambridge University’s Judge Business School, focused on Venture Capital business models in emerging economies; MCom in Economics, and BA in Politics, Economics and International Relations from the University of Witwatersrand. He has published widely on entrepreneurship, venture capital, and market trends in energy and healthcare. He is an Associate Fellow at Chatham House.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.